Diptoindonesin G promotes ERK-mediated nuclear translocation of p-STAT1 (Ser727) and cell differentiation in AML cells

Cell Death and Disease

Volumn 8, Issue 5, 2017, Pages

  Gao, Jian ^a   Fan, Minmin ^a   Xiang, Gang ^a   Wang, Jujuan ^b   Zhang, Xiong ^a   Guo, Wenjie ^a   Wu, Xuefeng ^a   Sun, Yang ^a   Gu, Yanhong ^b   Ge, Huiming ^a   Tan, Renxiang ^a   Qiu, Hongxia ^b   Shen, Yan ^a   Xu, Qiang ^a  

^a NANJING UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DIPTOINDONESIN G; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESVERATROL; STAT1 PROTEIN; UNCLASSIFIED DRUG; BENZOFURAN DERIVATIVE; CASPASE 3; CASPASE INHIBITOR; IFIT3 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; SIGNAL PEPTIDE;

ACUTE MYELOID LEUKEMIA; ANIMAL EXPERIMENT; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION PROFILING; HL-60 CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; M PHASE CELL CYCLE CHECKPOINT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; TUMOR VOLUME; TUMOR XENOGRAFT; U-937 CELL LINE; UPREGULATION; ANIMAL; CELL NUCLEUS; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHOSPHORYLATION; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZOFURANS; CASPASE 3; CASPASE INHIBITORS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CHEMOKINE CXCL10; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HL-60 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, INBRED NOD; MICE, SCID; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 85037648590     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2017.159     Document Type: Article

References (44)

1. Estey EH. Acute myeloid leukemia: 2014 update on risk-stratification and management. Am J Hematol 2014; 89: 1063-1081.
2. Hu S, Ueda M, Stetson L, Ignatz-Hoover J, Moreton S, Chakrabarti A et al. A novel glycogen synthase kinase-3 inhibitor optimized for acute myeloid leukemia differentiation activity. Mol Cancer Ther 2016; 15: 1485-1494.
3. Coombs CC, Tavakkoli M, Tallman MS. Acute promyelocytic leukemia: where did we start, where are we now, and the future. Blood Cancer J 2015; 5: e304.
4. Pisano C, Kollar P, Gianni M, Kalac Y, Giordano V, Ferrara FF et al. Bis-indols: A novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells. Blood 2002; 100: 3719-3730.
5. Glasow A, Barrett A, Petrie K, Gupta R, Boix-Chornet M, Zhou DC et al. DNA methylationindependent loss of RARA gene expression in acute myeloid leukemia. Blood 2008; 111: 2374-2377.
6. Sakamoto K, Imamura T, Yano M, Yoshida H, Fujiki A, Hirashima Y et al. Sensitivity of MLLrearranged AML cells to all-Trans retinoic acid is associated with the level of H3K4me2 in the RARalpha promoter region. Blood Cancer J 2014; 4: e205.
7. Kim K, Kim I. Total synthesis of diptoindonesin G via a highly efficient domino cyclodehydration/intramolecular Friedel-Crafts acylation/regioselective demethylation sequence. Org Lett 2010; 12: 5314-5317.
8. Juliawaty LD, Sahidin, Hakim EH, Achmad SA, Syah YM, Latip J et al. A 2-Arylbenzofuran derivative from Hopea mengarawan. Nat Prod Commun 2009; 4: 947-950.
9. Ge HM, Yang WH, Shen Y, Jiang N, Guo ZK, Luo Q et al. Immunosuppressive resveratrol aneuploids from Hopea chinensis. Chemistry 2010; 16: 6338-6345.
10. Zhao Z, Wang L, James T, Jung Y, Kim I, Tan R et al. Reciprocal regulation of ERalpha and ERbeta stability and activity by diptoindonesin G. Chem Biol 2015; 22: 1608-1621.
11. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998; 92: 996-1002.
12. Asou H, Koshizuka K, Kyo T, Takata N, Kamada N, Koeffier HP. Resveratrol, a natural product derived from grapes, is a new inducer of differentiation in human myeloid leukemias. Int J Hematol 2002; 75: 528-533.
13. Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, Kantarjian HM et al. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003; 102: 987-995.
14. Roberti M, Pizzirani D, Recanatini M, Simoni D, Grimaudo S, Di Cristina A et al. Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. J Med Chem 2006; 49: 3012-3018.
15. Shao X, Liu Y, Li Y, Xian M, Zhou Q, Yang B et al. The HER2 inhibitor TAK165 sensitizes human acute myeloid leukemia cells to retinoic acid-induced myeloid differentiation by activating MEK/ERK mediated RARalpha/STAT1 axis. Sci Rep 2016; 6: 24589.
16. Ying M, Zhou X, Zhong L, Lin N, Jing H, Luo P et al. Bortezomib sensitizes human acute myeloid leukemia cells to all-Trans-retinoic acid-induced differentiation by modifying the RARalpha/STAT1 axis. Mol Cancer Ther 2013; 12: 195-206.
17. Fang Y, Zhong L, Lin M, Zhou X, Jing H, Ying M et al. MEK/ERK dependent activation of STAT1 mediates dasatinib-induced differentiation of acutemyeloid leukemia. PLoS ONE 2013; 8: e66915.
18. Gianni M, Terao M, Fortino I, LiCalzi M, Viggiano V, Barbui T et al. Stat1 is induced and activated by all-Trans retinoic acid in acute promyelocytic leukemia cells. Blood 1997; 89: 1001-1012.
19. Battle TE, Frank DA. STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1. Blood 2003; 102: 3016-3024.
20. Shuai K, Schindler C, Prezioso VR, Darnell JE Jr. Activation of transcription by IFN-gamma: Tyrosine phosphorylation of a 91-kD DNA binding protein. Science 1992; 258: 1808-1812.
21. Hsu CL, Kikuchi K, Kondo M. Activation of mitogen-Activated protein kinase kinase (MEK)/extracellular signal regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment. Blood 2007; 110: 1420-1428.
22. Miranda MB, Johnson DE. Signal transduction pathways that contribute to myeloid differentiation. Leukemia 2007; 21: 1363-1377.
23. Nielsen SR, Hammer T, Gibson J, Pepper MS, Nisato RE, Dissing S et al. IL-27 inhibits lymphatic endothelial cell proliferation by STAT1-regulated gene expression. Microcirculation 2013; 20: 555-564.
24. Xiao S, Li D, Zhu HQ, Song MG, Pan XR, Jia PM et al. RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins. Proc Natl Acad Sci USA 2006; 103: 16448-16453.
25. Dimberg A, Karlberg I, Nilsson K, Oberg F. Ser727/Tyr701-phosphorylated Stat1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells. Blood 2003; 102: 254-261.
26. Dimberg A, Nilsson K, Oberg F. Phosphorylation-deficient Stat1 inhibits retinoic acid-induced differentiation and cell cycle arrest in U-937 monoblasts. Blood 2000; 96: 2870-2878.
27. Milligan DW, Wheatley K, Littlewood T, Craig JI, Burnett AK, NHOCS Group. Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial. Blood 2006; 107: 4614-4622.
28. Gocek E, Marcinkowska E. Differentiation therapy of acute myeloid leukemia. Cancers 2011; 3: 2402-2420.
29. Zhang JJ, Zhao Y, Chait BT, Lathem WW, Ritzi M, Knippers R et al. Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation. EMBO J 1998; 17: 6963-6971.
30. Tsuboi H, Wakamatsu E, Iizuka M, Nakamura Y, Sugihara M, Suzuki T et al. Importance of serine727 phosphorylated STAT1 in IFNgamma-induced signaling and apoptosis of human salivary gland cells. Int J Rheum Dis 2011; 14: 86-91.
31. Zhu X, Wen Z, Xu LZ, Darnell JE Jr. Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol Cell Biol 1997; 17: 6618-6623.
32. Usacheva A, Smith R, Minshall R, Baida G, Seng S, Croze E et al. The WD motif-containing protein receptor for activated protein kinase C (RACK1) is required for recruitment and activation of signal transducer and activator of transcription 1 through the type I interferon receptor. J Biol Chem 2001; 276: 22948-22953.
33. Lackmann M, Harpur AG, Oates AC, Mann RJ, Gabriel A, Meutermans Wet al. Biomolecular interaction analysis of IFN gamma-induced signaling events in whole-cell lysates: prevalence of latent STAT1 in high-molecular weight complexes. Growth Factors 1998; 16: 39-51.
34. Jia H, Dilger P, Bird C, Wadhwa M. IL-27 promotes proliferation of human leukemic cell lines through the MAPK/ERK signaling pathway and suppresses sensitivity to chemotherapeutic drugs. J Interferon Cytokine Res 2016; 36: 302-316.
35. Wang L, Li W, Yang Y, Hu Y, Gu Y, Shu Y et al. High expression of sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase 2b blocks cell differentiation in human liposarcoma cells. Life Sci 2014; 99: 37-43.
36. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M et al. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 1997; 100: 1813-1821.
37. Yoon S, Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 2006; 24: 21-44.
38. Mohi MG, Neel BG. The role of Shp2 (PTPN11) in cancer. Curr Opin Genet Dev 2007; 17: 23-30.
39. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940-954.
40. Elgehama A, Chen W, Pang J, Mi S, Li J, Guo W et al. Blockade of the interaction between Bcr-Abl and PTB1B by small molecule SBF-1 to overcome imatinib-resistance of chronic myeloid leukemia cells. Cancer Lett 2016; 372: 82-88.
41. Wang L, Wang L, Gu Y, Shu Y, Shen Y, Xu Q. Integrin alpha6(high) cell population functions as an initiator in tumorigenesis and relapse of human liposarcoma. Mol Cancer Ther 2011; 10: 2276-2286.
42. Yang B, Zhang M, Gao J, Li J, Fan L, Xiang G et al. Small molecule RL71 targets SERCA2 at a novel site in the treatment of human colorectal cancer. Oncotarget 2015; 6: 37613-37625.
43. Abaza L, Talorete TP, Yamada P, Kurita Y, Zarrouk M, Isoda H. Induction of growth inhibition and differentiation of human leukemia HL-60 cells by a Tunisian gerboui olive leaf extract. Bioscie Biotechnol Biochem 2007; 71: 1306-1312.
44. Fang XY, Song R, Chen W, Yang YY, Gu YH, Shu YQ et al. PRL-3 promotes the malignant progression of melanoma via triggering dephosphorylation and cytoplasmic localization of NHERF1. J Invest Dermatol 2015; 135: 2273-2282.